N3T-27952-18643
4 vaccinations
2 coded responses
53 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 358 / AL
- Registered
- 2021-04-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
RS9-68401-49179
Child or adolescent in my care · Female · 2022-06-20
VT2-30680-90386
Child or adolescent in my care · Male · 2023-01-04
Timeline
-
2021-04-01
Registered in v-safe
-
2021-04-01
Dose 1 — Moderna
- 2021-04-01
-
2021-04-02
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-15
- 2021-04-22
-
2021-04-29
Dose 2 — Moderna
- 2021-04-29
-
2021-04-30
Survey response — days 1–6 daily, dose 2MedDRA: Hot flush — Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Hot flashesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-01
- 2021-05-02
- 2021-05-03
- 2021-05-04
- 2021-05-05
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-05-27
- 2021-06-03
- 2021-06-10
-
2021-07-29
Survey response — 3 months, dose 2MedDRA: Discharge, Hypersensitivity, Pre-existing disease, Respiratory tract congestion — Feeling: GoodFree text: Drainage/congestion from allergies being aggravated by dustMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-10-28
-
2021-11-27
Dose 3 — Moderna
- 2021-11-27
- 2021-11-28
-
2021-11-29
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-11-30
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2021-12-01
- 2021-12-02
- 2021-12-03
- 2021-12-04
- 2021-12-11
- 2021-12-18
- 2021-12-25
- 2022-01-01
- 2022-01-08
- 2022-02-26
- 2022-05-28
-
2022-09-09
Dose 4 — Pfizer-BioNTech
- 2022-09-09
- 2022-09-10
- 2022-09-11
- 2022-09-12
- 2022-09-13
- 2022-09-16
- 2022-09-23
- 2022-09-30
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-12-09
- 2023-03-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Moderna | |
| 2 | 2021-04-29 | Moderna | |
| 3 | 2021-11-27 | Moderna | No |
| 4 | 2022-09-09 | Pfizer-BioNTech | No |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Hot flashes
Release 9 — 3 months, dose 2
Symptoms: Drainage/congestion from allergies being aggravated by dust
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Discharge | ✓ | · | ✓ |
| SD | Hypersensitivity | ✓ | · | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Respiratory tract congestion | ✓ | · | ✓ |
| SD | Rhinorrhoea | ○ | · | ○ |
| SRO | Hot flush | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release